#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	2188	16S	1529	1529	99.93	16S.l15.c4.ctg.1	2058	196.6	0	.	n	.	0	C1450T	SNP	1450	1450	C	1746	1746	T	226	T,G	144,2	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	2188	16S	1529	1529	99.93	16S.l15.c4.ctg.1	2058	196.6	1	SNP	n	C1184T	0	.	.	1184	1184	C	1480	1480	C	272	C	163	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	2188	16S	1529	1529	99.93	16S.l15.c4.ctg.1	2058	196.6	0	HET	.	.	.	A1039G	.	1039	1039	A	1335	1335	A	234	A,G	114,41	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	3908	23S	2890	2890	99.83	23S.l15.c4.ctg.1	3714	195.1	0	.	n	.	0	T695C	SNP	695	695	T	1113	1113	C	259	C	153	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	3908	23S	2890	2890	99.83	23S.l15.c4.ctg.1	3714	195.1	0	.	n	.	0	G1337A	SNP	1337	1337	G	1755	1755	A	193	A	128	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	3908	23S	2890	2890	99.83	23S.l15.c4.ctg.1	3714	195.1	0	.	n	.	0	A1638G	SNP	1638	1638	A	2056	2056	G	204	G,A	96,39	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	3908	23S	2890	2890	99.83	23S.l15.c4.ctg.1	3714	195.1	0	.	n	.	0	T1971C	SNP	1971	1971	T	2389	2389	C	220	C	139	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	3908	23S	2890	2890	99.83	23S.l15.c4.ctg.1	3714	195.1	1	SNP	n	C2597T	1	C2597T	SNP	2597	2597	C	3015	3015	T	234	T,G	154,1	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	3908	23S	2890	2890	99.83	23S.l15.c4.ctg.1	3714	195.1	1	SNP	n	A2045G	0	.	.	2045	2045	A	2463	2463	A	233	A	151	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
folP.WHO_O_01412c	folP.WHO_O_01412c	1	1	27	158	folP	855	855	99.88	folP.l15.c4.ctg.1	1343	22.1	1	SNP	p	R229S	1	.	.	685	687	AGC	778	780	AGC	19;19;19	A;G;C	13;11;11	folP.WHO_O_01412c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	0	366	gyrA	2751	2241	99.82	gyrA.l15.c4.ctg.1	2519	22.9	1	SNP	p	S91F	1	.	.	271	273	TTC	549	551	TTC	28;28;28	T;T;C	21;19;19	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	0	366	gyrA	2751	2241	99.82	gyrA.l15.c4.ctg.1	2519	22.9	1	SNP	p	G95N	0	.	.	283	285	GGC	561	563	GGC	32;32;32	G;G;C	23;22;23	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	0	366	gyrA	2751	2241	99.82	gyrA.l15.c4.ctg.1	2519	22.9	1	SNP	p	D95G	1	.	.	283	285	GGC	561	563	GGC	32;32;32	G;G;C	23;22;23	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	0	366	gyrA	2751	266	100.0	gyrA.l15.c4.ctg.2	479	17.3	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
mtrR.WHO_X_01389	mtrR.WHO_X_01389	1	1	27	126	mtrR	633	633	100.0	mtrR.l15.c4.ctg.1	1251	19.8	1	SNP	p	G45D	0	.	.	133	135	GGC	404	406	GGC	40;40;39	G;G;C	27;27;26	mtrR.WHO_X_01389:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	96	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c4.ctg.1	925	20.6	0	.	n	.	0	A197.	DEL	197	197	A	535	535	A	44	A	26	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	350	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3035	22.0	1	SNP	p	D86N	0	.	.	256	258	GAC	493	495	GAC	34;34;34	G;A;C	21;20;22	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	350	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3035	22.0	1	SNP	p	R87W	0	.	.	259	261	CGT	496	498	CGT	34;34;35	C;G;T	24;20;19	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	350	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3035	22.0	1	SNP	p	S87R	1	.	.	259	261	CGT	496	498	CGT	34;34;35	C;G;T	24;20;19	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	350	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3035	22.0	1	SNP	p	R87I	0	.	.	259	261	CGT	496	498	CGT	34;34;35	C;G;T	24;20;19	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	350	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3035	22.0	1	SNP	p	S88P	0	.	.	262	264	TCC	499	501	TCC	35;35;35	T;C;C	24;19;24	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	324	parE	1986	1986	100.0	parE.l15.c4.ctg.1	2349	23.5	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1434	1436	GGC	19;19;19	G;G;C	10;12;12	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.5.002	penA.5.002	1	1	27	386	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2283	30.7	1	SNP	p	A311V	0	.	.	931	933	GCA	1191	1193	GCA	53;53;53	G;C,A;A	34;33,1;33	penA.5.002:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	386	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2283	30.7	1	SNP	p	I312M	0	.	.	934	936	ATC	1194	1196	ATC	53;53;53	A;T;C	34;33;33	penA.5.002:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	386	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2283	30.7	1	SNP	p	V316P	0	.	.	946	948	GTG	1206	1208	GTG	53;53;53	G;T;G	34;32;33	penA.5.002:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	386	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2283	30.7	1	SNP	p	V316T	0	.	.	946	948	GTG	1206	1208	GTG	53;53;53	G;T;G	34;32;33	penA.5.002:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	386	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2283	30.7	1	SNP	p	T484S	0	.	.	1450	1452	ACC	1710	1712	ACC	18;18;20	A;C;C	12;12;14	penA.5.002:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	386	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2283	30.7	1	SNP	p	A502P	0	.	.	1504	1506	GCG	1764	1766	GCG	18;18;18	G;C;G	12;13;12	penA.5.002:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	386	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2283	30.7	1	SNP	p	A502V	0	.	.	1504	1506	GCG	1764	1766	GCG	18;18;18	G;C;G	12;13;12	penA.5.002:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	386	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2283	30.7	1	SNP	p	G543S	1	.	.	1627	1629	AGC	1887	1889	AGC	21;21;21	A;G;C,A	9;11;11,1	penA.5.002:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	386	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2283	30.7	1	SNP	p	G546S	0	.	.	1636	1638	GGC	1896	1898	GGC	21;19;18	G;G;C	14;11;10	penA.5.002:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	386	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2283	30.7	1	SNP	p	P552S	0	.	.	1654	1656	CCG	1914	1916	CCG	19;20;20	C;C;G	10;11;10	penA.5.002:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	682	ponA	2397	2397	100.0	ponA.l15.c4.ctg.1	3395	36.2	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1682	1684	CCG	32;32;32	C;C;G,C	19;19;19,1	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	214	porA	1146	1146	99.91	porA.l6.c17.ctg.1	1799	21.1	0	.	p	.	0	M83fs	FSHIFT	247	247	A	401	401	C	15	C	9	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	246	porB1b	1047	1047	98.76	porB1b.l15.c4.ctg.1	1616	30.0	0	.	p	.	0	A26T	NONSYN	76	78	GCC	332	334	ACC	34;34;33	A;C;C	23;23;23	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	246	porB1b	1047	1047	98.76	porB1b.l15.c4.ctg.1	1616	30.0	0	.	p	.	0	D41K	NONSYN	121	123	GAC	377	379	AAA	44;45;45	A;A;A	29;31;29	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	246	porB1b	1047	1047	98.76	porB1b.l15.c4.ctg.1	1616	30.0	1	SNP	p	G120K	1	G120K	NONSYN	358	360	GGC	614	616	AAG	30;30;30	A;A;G	19;20;19	porB1b.WHO_P_02204c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	246	porB1b	1047	1047	98.76	porB1b.l15.c4.ctg.1	1616	30.0	0	.	p	.	0	D121G	NONSYN	361	363	GAC	617	619	GGC	30;29;29	G;G;C	19;18;17	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	246	porB1b	1047	1047	98.76	porB1b.l15.c4.ctg.1	1616	30.0	0	.	p	.	0	N134D	NONSYN	400	402	AAT	656	658	GAT	30;31;31	G;A;T	20;21;21	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	246	porB1b	1047	1047	98.76	porB1b.l15.c4.ctg.1	1616	30.0	0	.	p	.	0	Q187R	NONSYN	559	561	CAA	815	817	CGA	30;30;28	C;G;A	21;21;20	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	246	porB1b	1047	1047	98.76	porB1b.l15.c4.ctg.1	1616	30.0	0	.	p	.	0	S189G	NONSYN	565	567	AGC	821	823	GGC	28;28;27	G;G;C	20;21;18	.	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	860	rpoB	4179	4179	99.98	rpoB.l15.c4.ctg.1	4938	33.9	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	74	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	954	16.8	1	SNP	p	V57M	1	.	.	169	171	ATG	476	478	ATG	30;30;30	A;T;G	21;21;21	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
